Context:
The effect of underweight and obesity on mortality has not been well characterized in Asian populations.
Objective:
To examine the relationship between body mass index (BMI) and mortality in Chinese adults.
Design, Setting, And Participants:
A prospective cohort study in a nationally representative sample of 169,871 Chinese men and women aged 40 years or older. Data on body weight and covariables were obtained at a baseline examination in 1991 using a standard protocol. Follow-up evaluation was conducted in 1999-2000, with a response rate of 93.4% (n = 158,666).
Main Outcome Measures:
Body mass index and all-cause mortality.
Results:
After excluding those participants with missing body weight or height values, 154,736 adults were included in the analysis. After adjustment for age, sex, cigarette smoking, alcohol consumption, physical activity, education, geographic region (north vs south), and urbanization (urban vs rural), a U-shaped association between BMI and all-cause mortality was observed (P<.001). Using those participants with a BMI of 24.0 to 24.9 as the reference group, the relative risks of all-cause mortality across categories of BMI were 1.65 (95% confidence interval [CI], 1.54-1.77) for BMI less than 18.5, 1.31 (95% CI, 1.22-1.41) for BMI 18.5 to 19.9, 1.20 (95% CI, 1.11-1.29) for BMI 20.0 to 20.9, 1.12 (95% CI, 1.04-1.21) for BMI 21.0 to 21.9, 1.11 (95% CI, 1.03-1.20) for BMI 22.0 to 22.9, 1.09 (95% CI, 1.01-1.19) for BMI 23.0 to 23.9, 1.00 (95% CI, 0.92-1.08) for BMI 25.0 to 26.9, 1.15 (95% CI, 1.06-1.24) for BMI 27.0 to 29.9, and 1.29 (95% CI, 1.16-1.42) for BMI 30.0 or more. The U-shaped association existed even after excluding participants who were current or former smokers, heavy alcohol drinkers, or who had prevalent chronic illness at the baseline examination, or who died during the first 3 years of follow-up. A similar association was observed between BMI and mortality from cardiovascular disease, cancer, and other causes.
Conclusions:
Our results indicate that both underweight and obesity were associated with increased mortality in the Chinese adult population. Furthermore, our findings support the use of a single common recommendation for defining overweight and obesity among all racial and ethnic groups.
Citing Articles
A Preliminary Study on Factors That Drive Patient Variability in Human Subcutaneous Adipose Tissues.
DeBari M, Johnston E, Scott J, Ilzuka E, Sun W, Webster-Wood V
Cells. 2024; 13(15.
PMID: 39120271
PMC: 11311805.
DOI: 10.3390/cells13151240.
Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes.
Almuwaqqat Z, Hui Q, Liu C, Zhou J, Voight B, Ho Y
JAMA Netw Open. 2024; 7(3):e243062.
PMID: 38512255
PMC: 10958234.
DOI: 10.1001/jamanetworkopen.2024.3062.
Association of body mass index with risk of cardiometabolic disease, multimorbidity and mortality: a multi-state analysis based on the Kailuan cohort.
Xia X, Chen S, Tian X, Xu Q, Zhang Y, Zhang X
Endocrine. 2023; 84(2):355-364.
PMID: 37878230
DOI: 10.1007/s12020-023-03570-w.
Prognostic risk factors for postoperative long-term outcomes in elderly stage IA gastric cancer patients.
Kakiuchi Y, Kuroda S, Kikuchi S, Kagawa S, Fujiwara T
J Gastrointest Oncol. 2022; 13(5):2178-2185.
PMID: 36388703
PMC: 9660044.
DOI: 10.21037/jgo-22-527.
Hypertension modifies the associations of body mass index and waist circumference with all-cause mortality among older Chinese: a retrospective cohort study.
Bai K, Chen X, Shi Z, He K, Hu X, Song R
BMC Geriatr. 2022; 22(1):441.
PMID: 35590286
PMC: 9118767.
DOI: 10.1186/s12877-022-03057-9.
U-Shaped Association between Waist-to-Hip Ratio and All-Cause Mortality in Stage 3-5 Chronic Kidney Disease Patients with Body Mass Index Paradox.
Shen F, Chiu Y, Kuo M, Lin M, Jia-Jung Lee , Hwang S
J Pers Med. 2021; 11(12).
PMID: 34945829
PMC: 8703404.
DOI: 10.3390/jpm11121355.
The East Asian gut microbiome is distinct from colocalized White subjects and connected to metabolic health.
Ang Q, Alba D, Upadhyay V, Bisanz J, Cai J, Lee H
Elife. 2021; 10.
PMID: 34617511
PMC: 8612731.
DOI: 10.7554/eLife.70349.
Impact of Body Mass Index on the Survival of Patients with Sepsis with Different Modified NUTRIC Scores.
Tsai Y, Lin C, Chen Y, Chang Y, Hung K, Chang Y
Nutrients. 2021; 13(6).
PMID: 34070883
PMC: 8226650.
DOI: 10.3390/nu13061873.
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on Asia.
Ji Q, Ji L, Mu Y, Zhao J, Zinman B, Wanner C
Diabetes Obes Metab. 2021; 23(8):1886-1891.
PMID: 33950573
PMC: 8361954.
DOI: 10.1111/dom.14415.
BMI and risk of all-cause mortality in normotensive and hypertensive adults: the rural Chinese cohort study.
Zhou Q, Liu X, Zhao Y, Qin P, Ren Y, Liu D
Public Health Nutr. 2021; 24(17):5805-5814.
PMID: 33861189
PMC: 10195626.
DOI: 10.1017/S1368980021001592.
Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: Results from four prospective cohorts.
Cheng Y, Chen Z, Wu S, Mei W, Yao F, Zhang M
EClinicalMedicine. 2021; 33:100790.
PMID: 33778436
PMC: 7985466.
DOI: 10.1016/j.eclinm.2021.100790.
Measurement Error in Body Mass Index May Affect Trajectory Modeling.
Pollack J, Cheng T
Am J Public Health. 2021; 111(4):e22-e23.
PMID: 33689431
PMC: 7958045.
DOI: 10.2105/AJPH.2021.306162.
Dietary Energy Partition: The Central Role of Glucose.
Remesar X, Alemany M
Int J Mol Sci. 2020; 21(20).
PMID: 33086579
PMC: 7593952.
DOI: 10.3390/ijms21207729.
Body Mass Index Trajectory and Incident Hypertension: Results From a Longitudinal Cohort of Chinese Children and Adolescents, 2006-2016.
Wang X, Dong B, Huang S, Ma Y, Zou Z, Ma J
Am J Public Health. 2020; 110(11):1689-1695.
PMID: 32941067
PMC: 7542296.
DOI: 10.2105/AJPH.2020.305873.
Adipose Tissue Fibrosis: Mechanisms, Models, and Importance.
DeBari M, Abbott R
Int J Mol Sci. 2020; 21(17).
PMID: 32825788
PMC: 7503256.
DOI: 10.3390/ijms21176030.
Deaths from total and premature cardiovascular disease associated with high normal blood pressure and hypertension in rural Chinese men and elderly people.
Liu L, Liu Y, Ren Y, Zhao Y, Qin P, Liu D
J Hum Hypertens. 2020; 35(8):741-750.
PMID: 32690863
DOI: 10.1038/s41371-020-0379-4.
Forecasting the prevalence of overweight and obesity in India to 2040.
Luhar S, Timaeus I, Jones R, Cunningham S, Patel S, Kinra S
PLoS One. 2020; 15(2):e0229438.
PMID: 32092114
PMC: 7039458.
DOI: 10.1371/journal.pone.0229438.
Adiposity and mortality in older Chinese: an 11-year follow-up of the Guangzhou Biobank Cohort Study.
Jiang C, Xu L, Zhang W, Jin Y, Zhu F, Cheng K
Sci Rep. 2020; 10(1):1924.
PMID: 32024868
PMC: 7002501.
DOI: 10.1038/s41598-020-58633-z.
The PROMOTE study (High-protein and resistance-training combination in overweight and obesity) for short-term weight loss and long-term weight maintenance for Chinese people: a protocol for a pilot randomized controlled trial.
Xu S, Zhang J, Dong Y, Chen R, Xu W, Tan Z
Trials. 2020; 21(1):47.
PMID: 31915038
PMC: 6950796.
DOI: 10.1186/s13063-019-3954-7.
Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes.
Lee J, Kim J, Hong A, Kim S, Shin C
Korean J Intern Med. 2019; 35(6):1432-1442.
PMID: 31564086
PMC: 7652649.
DOI: 10.3904/kjim.2018.223.